Test
Chlamydia Trachomatis and Neisseria Gonorrhea
Other Test Request Name
CTNG
Test Composition
Chlamydia Trachomatis and Neisseria Gonorrhea
Intended Use
C. trachomatisinfections are the leading cause of sexually transmitted diseases in the United States.C. trachomatisis known to cause cervicitis, pelvic inflammatory disease (PID), epididymitis and proctitis. It is also the most frequent cause of non-gonococcal urethritis in men. Among women, the consequences ofChlamydialinfections are severe if left untreated. Approximately half ofChlamydialinfections are asymptomatic.
Neisseria gonorrhoeae(gonococci) is the causative agent of gonorrhea. In men, this disease generally results in anterior urethritis accompanied by purulent exudate. In women, the disease is most often found in the cervix, but the vagina and uterus may also be infected.
Methodology
Rapid Antigen
Laboratory Section
Special test
Special Instructions/Patient Preparations
• Collection kit must be requested 2 days prior to collection.
• 1 Swab for FEMALE
• Urine sample for MALE
Collection/Sample Container
NOTE: Kit provided by HPD
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
• 1 cervicovaginal or urethral swab collected using provided collection kit.
• 60 ml of Random urine
Alternative Specimen and Volume Requirement
Not Applicable
Specimen Stability
• Room Temperature (15-25°C)
7 Days
• Refrigerated Temperature (2-8°C)
7 Days
• Freezer Temperature (-20°C)
Not applicable
Transport Temperature
Transport specimen at 2°C - 8°C (with cold packs)
Rejection Criteria
• Dried and with blood contamination
• Exceed sample stability requirement
• Incorrect collection container used
• Improperly labeled specimen
Running Day
Monday to Friday
Cut Off Time
8:00 AM
TAT/Releasing of Results
After 3 days (excluding Saturdays, Sundays and Holidays)
Reference Interval/Result Interpretation
Not applicable
Limitations/Interferences
Not applicable
Frequently Asked Questions (FAQs)
Not applicabl
Related Words/Test
Not Applicable
Test
Chlamydia trachomatis IgA
Other Test Request Name
Test Composition
Not Applicable
Intended Use
C. trachomatis is known to cause cervicitis, pelvic inflammatory disease (PID), epididymitis and proctitis.
It is also the most frequent cause of non-gonococcal urethritis in men. Among women, the consequences of chlamydial infections are severe if left untreated. Approximately half of chlamydial infections are asymptomatic.
Bacterium which only infects the eyes and the genitalia. It usually causes trachoma, inclusion conjunctivitis or sexually transmitted disease. Lymphogranuloma venereum remains an exotic infection. "Non-specific" urethritis and cervicitis can be relatively asymptomatic and lead to spread of the infection and ultimately tubular damage and infertility in women or epididymitis and prostatitis in men. A role for C. trachomatis has been suggested in some forms of perihepatitis and in Reiter's syndrome. Infants born to infected mothers may present with post-natal conjunctivitis (which is resistant to silver nitrate treatment) and severe pneumonia. The bacterium can often be directly detected in conjunctival or genital smears. Nucleic acid-based techniques (e.g. PCR) are sensitive, specific and do not necessitate invasive procedures (a urine specimen or a vulvar smear is suitable). Culture takes much longer and requires a urethral, cervical or conjunctival smear and perfect transport conditions. Seroconversion and the presence of IgM are demonstrated in cases of recent primary infection and in infected newborns. Apart from these situations, the presence of IgG indicates contact with the bacterium, which cannot be dated, in that these antibodies persist for a long time and are only influenced by an effective treatment at a late stage. The presence of specific IgA may be of interest in cases of active infection. Note the existence of serological cross-reactions between the different Chamydia species.
Methodology
Chemiluminescence
Laboratory Section
Special Tes
Special Instructions/Patient Preparations
Collection/Sample Container
Red or Gold Tube
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
3 mL Serum
Alternative Specimen and Volume Requirement
Not Applicable
Specimen Stability
• Room Temperature (15-25°C)
24 Hours
• Refrigerated Temperature (2-8°C)
7 Days
• Freezer Temperature (-20°C)
28 Days
Transport Temperature
Transport specimen at 2°C - 8°C (with cold packs)
Rejection Criteria
Running Day
Batch running
Cut Off Time
Friday, 4:00 PM
TAT/Releasing of Results
2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)
Reference Interval/Result Interpretation
Available upon request
Limitations/Interferences
Interference possible in patients treated with biotin (vitamin B7, B8 or H) or taking any food supplement containing biotin. Essential to STOP treatment 8 days before taking the sample.
Frequently Asked Questions (FAQs)
Not applicable
Related Words/Test
Sexually transmitted bacterial infection
Test
Chlamydia trachomatis IgG
Other Test Request Name
Test Composition
Not applicable
Intended Use
C. trachomatis is known to cause cervicitis, pelvic inflammatory disease (PID), epididymitis and proctitis.
It is also the most frequent cause of non-gonococcal urethritis in men. Among women, the consequences of chlamydial infections are severe if left untreated. Approximately half of chlamydial infections are asymptomatic.
Bacterium which only infects the eyes and the genitalia. It usually causes trachoma, inclusion conjunctivitis or sexually transmitted disease. Lymphogranuloma venereum remains an exotic infection. "Non-specific" urethritis and cervicitis can be relatively asymptomatic and lead to spread of the infection and ultimately tubular damage and infertility in women or epididymitis and prostatitis in men. A role for C. trachomatis has been suggested in some forms of perihepatitis and in Reiter's syndrome. Infants born to infected mothers may present with post-natal conjunctivitis (which is resistant to silver nitrate treatment) and severe pneumonia. The bacterium can often be directly detected in conjunctival or genital smears. Nucleic acid-based techniques (e.g. PCR) are sensitive, specific and do not necessitate invasive procedures (a urine specimen or a vulvar smear is suitable). Culture takes much longer and requires a urethral, cervical or conjunctival smear and perfect transport conditions. Seroconversion and the presence of IgM are demonstrated in cases of recent primary infection and in infected newborns. Apart from these situations, the presence of IgG indicates contact with the bacterium, which cannot be dated, in that these antibodies persist for a long time and are only influenced by an effective treatment at a late stage. The presence of specific IgA may be of interest in cases of active infection. Note the existence of serological cross-reactions between the different Chamydia species.
Methodology
Chemiluminescence
Laboratory Section
Special Test
Special Instructions/Patient Preparations
No patient preparation necessary.
NOTE: Interference possible in patients treated with biotin (vitamin B7, B8 or H) or taking any food supplement containing biotin. Essential to STOP treatment 8 days before taking the sample.
Collection/Sample Container
Red or Gold Tube
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
3 mL Serum
Alternative Specimen and Volume Requirement
Not Applicable
Specimen Stability
• Room Temperature (15-25°C)
72 Hours
• Refrigerated Temperature (2-8°C)
14 Days
• Freezer Temperature (-20°C)
28 Days
Transport Temperature
Transport specimen at 2°C - 8°C (with cold packs)
Rejection Criteria
• Hemolyzed specimen
• Quantity Not sufficient
• Markedly lipemic sample
• Improperly labeled specimen
Running Day
Batch running
Cut Off Time
Friday, 4:00 PM
TAT/Releasing of Results
2 Weeks after cut-off (Excluding Saturdays, Sundays and Holidays)
Reference Interval/Result Interpretation
Available upon request
Limitations/Interferences
None specified
Frequently Asked Questions (FAQs)
Not applicable
Related Words/Test
Gonorrhea Testing, HIV Antibody and HIV Antigen, Syphilis Tests, Herpes Testing, HPV Test, Trichomonas Testing
Test
Chlamydia trachomatis IgM
Other Test Request Name
It is also the most frequent cause of non-gonococcal urethritis in men. Among women, the consequences of chlamydial infections are severe if left untreated. Approximately half of chlamydial infections are asymptomatic.
Bacterium which only infects the eyes and the genitalia. It usually causes trachoma, inclusion conjunctivitis or sexually transmitted disease. Lymphogranuloma venereum remains an exotic infection. "Non-specific" urethritis and cervicitis can be relatively asymptomatic and lead to spread of the infection and ultimately tubular damage and infertility in women or epididymitis and prostatitis in men. A role for C. trachomatis has been suggested in some forms of perihepatitis and in Reiter's syndrome. Infants born to infected mothers may present with post-natal conjunctivitis (which is resistant to silver nitrate treatment) and severe pneumonia. The bacterium can often be directly detected in conjunctival or genital smears. Nucleic acid-based techniques (e.g. PCR) are sensitive, specific and do not necessitate invasive procedures (a urine specimen or a vulvar smear is suitable). Culture takes much longer and requires a urethral, cervical or conjunctival smear and perfect transport conditions. Seroconversion and the presence of IgM are demonstrated in cases of recent primary infection and in infected newborns. Apart from these situations, the presence of IgG indicates contact with the bacterium, which cannot be dated, in that these antibodies persist for a long time and are only influenced by an effective treatment at a late stage. The presence of specific IgA may be of interest in cases of active infection. Note the existence of serological cross-reactions between the different Chamydia species.
Methodology
Immunofluorescence
Laboratory Section
Special Test
Special Instructions/Patient Preparations
No patient preparation necessar
NOTE:Test not recommended for STD screening
Collection/Sample Container
Red or Gold tube
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
3 mL Serum
Alternative Specimen and Volume Requirement
Not Applicable
Specimen Stability
• Room Temperature (15-25°C)
72 Hours
• Refrigerated Temperature (2-8°C)
7 Days
• Freezer Temperature (-20°C)
28 Days
Transport Temperature
Transport specimen at 2°C - 8°C (with cold packs)
Rejection Criteria
Running Day
Batch running
Cut Off Time
Friday, 4:00 PM
TAT/Releasing of Results
2 Weeks after cut-off (Excluding Saturdays, Sundays and Holidays)
Reference Interval/Result Interpretation
Available upon request
Limitations/Interferences
None specified
Frequently Asked Questions (FAQs)
Not applicable
Related Words/Test
Gonorrhea Testing, HIV Antibody and HIV Antigen, Syphilis Tests, Herpes Testing, HPV Test, Trichomonas Testing
Test
Chloride
Other Test Request Name
•Cl
Test Composition
Not applicable
Intended Use
• Often ordered with other electrolytes as part of a regular physical to screen for a variety of conditions.
Methodology
Direct ISE
Laboratory Section
Chemistry
Special Instructions/Patient Preparations
• No patient preparation necessary.
Collection/Sample Container
Red or Gold tube
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
1-3 mL Serum
Alternative Specimen and Volume Requirement
1-3 mL Plasma (Heparin except for Na-Heparin)
Specimen Stability
• Room Temperature (15-25°C)
7 Days (Serum must be separated from Gel separator)
• Refrigerated Temperature (2-8°C)
4 Weeks (Serum must be separated from Gel separator)
• Freezer Temperature (-20°C)
Indefinite
Transport Temperature
Transport specimen at 2 – 8 °C (with cold packs)
Rejection Criteria
• Improper collection tube used
• Specimen stored/transported outside the temperature range
• Quantity not sufficient
• Hemolyzed specimen
• Lipemic specimen
• Improperly labeled specimen
• EDTA plasma
Running Day
DailyCut Off Time
Monday to Saturday:6:00 PM
Sunday:4:00PM
TAT/Releasing of Results
ROUTINE
• 4 hours after receipt of specimen/ arrival of messenger
STAT
• After 2½ HOURS from extraction/messenger arrival
Reference Interval/Result Interpretation
98.00-107.00 mmol/L (98.00-107.00 meq/L)
Limitations/Interferences
• Substances that may interfere with the assay: 5-aminosalicylic acid, glutathione, naproxen, terazosin
Frequently Asked Questions (FAQs)
Not applicable
Related Words/Test
Sodium, Potassium, Bicarbonate, Electrolytes, Comprehensive Metabolic Panel, Basic Metabolic Panel, Blood Gases
Test
Cholesterol (CHOD-PAP)
Other Test Request Name
• Total Cholesterol
• Blood Cholesterol
Test Composition
Not applicable
Intended Use
The test for total cholesterol is used alone or as part of a lipid profile to help predict an individual's risk of developing heart disease and to help make decisions about what treatment may be needed if there is borderline or high risk.
Methodology
Colorimetric, Enzymatic Method (CHOD-PAP)
Laboratory Section
Chemistry
Special Instructions/Patient Preparations
No patient preparation necessary.
Collection/Sample Container
Red or Gold tube
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
1-3 mL Serum
Alternative Specimen and Volume Requirement
1-3mL Plasma (Li?heparin and K2?EDTA)
Specimen Stability
• Room Temperature (15-25°C)
7 Days
• Refrigerated Temperature (2-8°C)
7 Days
• Freezer Temperature (-20°C)
3 Months
Transport Temperature
Transport specimen at 2 – 8 °C (with cold packs)
Rejection Criteria
Running Day
Daily
Cut Off Time
Monday to Saturday: 6:00 PM
Sunday: 4:00pm
TAT/Releasing of Results
RUNNING TIME: 6:00 AM onwards
RELEASING TIME: ROUTINE
• 4 hours after receipt of specimen/ arrival of messenger
RELEASING TIME: STAT
• After 2½ hours from extraction/messenger arrival
Reference Interval/Result Interpretation
NCEP Recommendations:
Desirable: <5.20 mmol/L (<200.00 mg/dL)
Borderline High: 5.20-6.20 mmol/L (200.00-239.38 mg/dL)
High: >/= 6.20 mmol/L (>/= 239.38 mg/dL)
Limitations/Interferences
Frequently Asked Questions (FAQs)
Q: When should testing for cholesterol/lipid profile be done?
A: In all adults aged 20 years or older, a fasting Lipid Profile should be obtained once every 5 years.
Q: Can cholesterol be done on non-fasting samples?
A: If the testing opportunity is nonfasting, only the values for total cholesterol and HDL cholesterol will be usable.
Related Words/Test
HDL Cholesterol, LDL Cholesterol, Triglycerides, Lipid Profile, Cardiac Risk Assessment
Test
Cholesterol HDL 2 & HDL 3
Other Test Request Name
Not applicable
Test Composition
Not applicable
Intended Use
The HDL Cholesterol fraction can be separated into sub-fractions by ultracentrifugation. The HDL2 sub-fraction consist of mostly LpA1 and the HDL3 sub-fraction HDL3 of mostly LpA1-A2. HDL2 can be influced by exercise and curtailing smoking, whilst HDL3 is genetically established.
Methodology
Ultracentrifugation
Laboratory Section
Special Test
Special Instructions/Patient Preparations
8 hours fasting.
Collection/Sample Container
Gold or Red Top
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
3 mL Serum
Alternative Specimen and Volume Requirement
Not Applicable
Specimen Stability
• Room Temperature (15-25°C)
24 Hours
• Refrigerated Temperature (2-8°C)
7 Days
• Freezer Temperature (-20°C)
14 Days
Transport Temperature
Transport specimen at 2°C - 8°C (with cold packs)
Rejection Criteria
• Hemolyzed specimen
• Quantity Not sufficient
• Markedly lipemic sample
• Improperly labeled specimen
Running Day
Batch running
Cut Off Time
Friday 4:00 PM
TAT/Releasing of Results
3 months after cut-off (excluding Saturdays, Sundays and Holidays)
Reference Interval/Result Interpretation
Available upon request
Limitations/Interferences
None specified
Frequently Asked Questions (FAQs)
Not applicable
Related Words/Test
HDL; HDL-C, High-density Lipoprotein Cholesterol
Test
Cholinesterase
Other Test Request Name
Test Composition
Not applicable
Intended Use
Helps to identify patients who may have adverse reactions to muscle relaxants.
Methodology
Wet Chem-Coupled Oxidation Reduction Indicator Reaction
Laboratory Section
Special Test
Special Instructions/Patient Preparations
Note if under medication
Collection/Sample Container
Gold or Red Top
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
3 mL Serum
Test
Chromium
Other Test Request Name
Not applicable
Test Composition
Not applicable
Intended Use
Widely used in industry such as dyes, paints and metallurgy processing. Acute poisoning results in skin, eye, respiratory and stomach involvement. Test used in occupational health.
Methodology
Inductively Coupled Plasma/Mass Spectrometry (ICP-MS)
Laboratory Section
Special Test
Special Instructions/Patient Preparations
Collection/Sample Container
Sodium Heparin (Green Top)
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
3 pcs. of 4mL Heparinized whole blood
Alternative Specimen and Volume Requirement
Not Applicable
Specimen Stability
• Room Temperature (15-25°C)
24 hours
• Refrigerated Temperature (2-8°C)
7 days
• Freezer Temperature (-20°C)
Not applicable
Transport Temperature
Transport specimen at 2°C - 8°C (with cold packs)
Rejection Criteria
Running Day
Batch running
Cut Off Time
Friday, 4:00 PM
TAT/Releasing of Results
3 weeks after cut-off (excluding Saturdays, Sundays and Holidays)
Reference Interval/Result Interpretation
Available upon request
Limitations/Interferences
None specified
Frequently Asked Questions (FAQs)
Not applicable
Related Words/Test
Toxic Metals , Heavy Metals Panel
Test
Cholesterol HDL 2 & HDL 3
Other Test Request Name
Not applicable
Test Composition
Not applicable
Intended Use
The HDL Cholesterol fraction can be separated into sub-fractions by ultracentrifugation. The HDL2 sub-fraction consist of mostly LpA1 and the HDL3 sub-fraction HDL3 of mostly LpA1-A2. HDL2 can be influced by exercise and curtailing smoking, whilst HDL3 is genetically established.
Methodology
Ultracentrifugation
Laboratory Section
Special Test
Special Instructions/Patient Preparations
8 hours fasting.
Collection/Sample Container
Gold or Red Top
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
3 mL Serum
Alternative Specimen and Volume Requirement
Not Applicable
Specimen Stability
• Room Temperature (15-25°C)
24 Hours
• Refrigerated Temperature (2-8°C)
7 Days
• Freezer Temperature (-20°C)
14 Days
Transport Temperature
Transport specimen at 2°C - 8°C (with cold packs)
Rejection Criteria
• Hemolyzed specimen
• Quantity Not sufficient
• Markedly lipemic sample
• Improperly labeled specimen
Test
Chromogranin A
Other Test Request Name
CgA
Test Composition
Not Applicable
Intended Use
To help diagnose and monitor carcinoid tumors and other neuroendocrine tumors
Proteins present in the secretory chromaffin granules of neuroendocrine cells. Very high levels associated with neuroendocrine tumors and pheochromocytoma, intestinal carcinoid and tumors of the endocrine pancreas
Chromogranin A (CgA) is a protein released from neuroendocrine cells. These are cells that secrete hormones in response to signals from the nervous system. They are found in organs throughout the body. This test measures the amount of chromogranin A in the blood.
Neuroendocrine cells, and the endocrine glands that they are found in, can give rise to a variety of tumors, both benign and malignan. Examples include carcinoid tumors, insulinomas, small cell lung cancers, and neuroblastomas. The CgA test may be used to help detect, diagnose, and/or monitor neuroendocrine tumors, especially carcinoid tumors.
Many of these tumors release large quantities of the hormone associated with that tissue, either continuously or intermittently, causing symptoms characteristic for that tumor. However, not all neuroendocrine tumors release the expected hormones. In either case, neuroendocrine tumors are frequently associated with increased concentrations of CgA.
Carcinoid tumors are slow-growing noncancerous or cancerous masses that form mainly in the gastrointestinal tract (especially in the appendix) and in the lungs. According to the American Cancer Society, there are about 8,000 gastrointestinal and 4,000 lung carcinoid tumors diagnosed each year in the United States. Many more of these tumors may exist, but most remain small and do not cause any symptoms. When carcinoid tumors are discovered in asymptomatic patients during surgical procedures performed for other reasons, they are called "incidental" tumors. A small percentage of these tumors may eventually grow large enough to cause obstructions in the intestines or bronchial tubes of the lungs.
Methodology
Enzyme Immunoassay (EIA)
Laboratory Section
Special Test
Special Instructions/Patient Preparations
Collection/Sample Container
Red or Gold Tube
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
3 mL Serum
Alternative Specimen and Volume Requirement
Not Applicable
Specimen Stability
• Room Temperature (15-25°C)
24 Hours
• Refrigerated Temperature (2-8°C)
7 Days
• Freezer Temperature (-20°C)
28 Days
Transport Temperature
Transport specimen at 2°C - 8°C (with cold packs)
Rejection Criteria
Running Day
Batch running
Cut Off Time
Friday, 4:00 PM
TAT/Releasing of Results
2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)
Reference Interval/Result Interpretation
Available upon request
Limitations/Interferences
None Specified
Frequently Asked Questions (FAQs)
Q: When to get tested?
A:When you have symptoms suggestive of a carcinoid tumor, such as flushing, diarrhea, and/or wheezing; when your healthcare provider thinks that you may have a carcinoid or other neuroendocrine tumor.
Q: When it is ordered?
A:A CgA test is ordered along with other tests when a healthcare practitioner suspects that a person's signs and symptoms are due to a carcinoid tumor or other neuroendocrine tumor.
Some signs and symptoms may include:
This test may be ordered periodically to help evaluate treatment effectiveness and monitor for tumor recurrence.
Test
Chromogranin Staining
Other Test Request Name
Not applicable
Test Composition
Not applicable
Intended Use
• It may also be used to detect the presence of other tumors arising from neuroendocrine cells.
Methodology
Immuno Histochemistry
Laboratory Section
Special Test
Special Instructions/Patient Preparations
No patient preparation necessary.
Collection/Sample Container
Slide holders or mailers for microscope slides; FFPE tissue blocks can either be wrapped in paper or placed in a box.
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
• Formalin-fixed paraffin-embedded (FFPE) tissue block
• 1 H&E stained slide representative of the submitted tissue block.
• Histopathology report for the submitted tissue block
Alternative Specimen and Volume Requirement
Not Applicable
Specimen Stability
• Room Temperature (15-25°C)
Indefinite
• Refrigerated Temperature (2-8°C)
Not applicable
• Freezer Temperature (-20°C)
Not applicableTransport Temperature
• Microscope slides should be placed in slide holders or mailers and should be adequately padded before placing in a shipping/packaging container to prevent breakage.
• FFPE tissue blocks must be placed in a box and avoid direct sunlight to prevent melting and disorientation during transport or shipping.
• Transport specimen at 15°C ~25 °C (room temperature)
Rejection Criteria
• Incomplete information in the Request Form
• Improper or insufficient labeling of tissue blocks or slides
• Inadequate tissue available on the tissue block
Running Day
Tuesday, Thursday and Saturday
Cut Off Time
Day before running day
TAT/Releasing of Results
10 days (excluding Saturdays, Sundays and Holidays)
Reference Interval/Result Interpretation
10 days (excluding Saturdays, Sundays and Holidays)
Limitations/Interferences
None specified.
Frequently Asked Questions (FAQs)
Not Applicable
Related Words/Test
Not Applicable
Test
COBALT (UNAVAILABILITY OF TUBE)
Other Test Request Name
Not Applicable
Test Composition
Not Applicable
Intended Use
Cobalt is part of our diet. Approximately 85% of absorbed cobalt is excreted in the urine and the remainder eliminated in stool. Toxicity may occur in select industrial environments. Cobalt is not mined in the United States so primary supplies are imported.
Methodology
Inductively Coupled Plasma/Mass Spectrometry (ICP/MS)
Laboratory Section
Special test
Special Instructions/Patient Preparations
Instruction to Phlebotomists:Specimen Collection and Handling
Collection/Sample Container
6 mL Royal Blue Tube (Whole Blood) - EDTA
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
2 pcs. of 6mL Royal Tube (Whole Blood) - EDTA
Alternative Specimen and Volume Requirement
Not Applicable
Specimen Stability
• Room Temperature (15-25°C)
48 hours
• Refrigerated Temperature (2-8°C)
5 days
• Freezer Temperature (-20°C)
Unacceptable
Transport Temperature
Transport specimen at 2 – 8 °C (with cold packs)
Rejection Criteria
Not Applicable
Running Day
Batch Running
Cut Off Time
Monday, 12:00 PM
TAT/Releasing of Results
2 weeks after cut off (excluding Saturdays, Sundays and Holidays)
Reference Interval/Result Interpretation
Not Applicable
Limitations/Interferences
Not Applicable
Frequently Asked Questions (FAQs)
Not Applicable
Related Words/Test
Not Applicable
Test
Cocaine
Other Test Request Name
• Coke
• Crack
• Gold dust
• Stardust
• White girl
• Speed balls
Test Composition
Not applicable
Intended Use
Used as a screening test for qualitative detection of cocaine in urine.
Methodology
Lateral Flow Immunochromatography (Competitive Binding)
Laboratory Section
Drug Test
Special Instructions/Patient Preparations
No patient preparation necessary
Collection/Sample Container
60-mL clean, screw cap, polyethylene container
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
60 mL urine
Alternative Specimen and Volume Requirement
Not applicable
Specimen Stability
• Room Temperature (15-25°C)
Not specified
• Refrigerated Temperature (2-8°C)
48 Hours
• Freezer Temperature (-20°C)
Not specified
Transport Temperature
Not applicable
Rejection Criteria
• Incompatibility of the ID number on the specimen received by the laboratory with the number on the CCF.
• Absence of ID number on the specimen
• No printed Authorized Specimen Collector’s name and signature on the CCF.
• Broken or tampered seal on the specimen container
• Insufficient quantity of specimen, below 60 mL for single collection; below 30 mL for spilt collection
Running Day
Daily
Cut Off Time
Monday to Saturday
• 6:00 PM
Sunday
• 3:00 PM
TAT/Releasing of Results
ROUTINE
• 3 hours after receipt of specimen/ arrival of messenger
STAT
• After 1½ hours from receipt of specimen/ arrival of messenger
Reference Interval/Result Interpretation
Not applicable
Limitations/Interferences
• Other drugs with the same structure with the abused drugs
• Cross-reactant chemicals
• Bleach or alum
Frequently Asked Questions (FAQs)
Not applicable
Related Words/Test
Recreational drug
Test
Coccidioides Panel
Other Test Request Name
Not applicable
Test Composition
1. Complement Fixation Titer
2. IgG ID (F Antigen)
3. IgM ID (TP Antigen)
Intended Use
Positive results suggest coccidioides infection.
Methodology
Complement Fixation (CF) and Immunodiffusion (ID)
Laboratory Section
Special Test
Special Instructions/Patient Preparations
No patient preparation necessary.
Collection/Sample Container
Gold or Red Top
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
3 mL Serum
Alternative Specimen and Volume Requirement
Not Applicable
Specimen Stability
• Room Temperature (15-25°C)
7 Days
• Refrigerated Temperature (2-8°C)
14 Days
• Freezer Temperature (-20°C)
30 Days
Transport Temperature
Transport specimen at 2°C - 8°C (with cold packs)
Rejection Criteria
• Hemolyzed specimen
• Quantity Not sufficient
• Markedly lipemic sample
• Improperly labeled specimen
Running Day
Batch running
Cut Off Time
Friday 4:00 PM
TAT/Releasing of Results
2 Weeks after cut-off (Excluding Saturdays, Sundays and Holidays)
Reference Interval/Result Interpretation
Available upon request
Limitations/Interferences
None specified
Frequently Asked Questions (FAQs)
Not applicable
Related Words/Test
Fungal infection